Diabetes Care 29 , 21022107 (2006)
BD 328431 Insulin Syringes are designed for injecting insulin into the subcutaneous tissue just under the skin. They are used by people with diabetes to self-administer insulin. The syringes have a needle with ultra-fine 30 gauge and a length of 12.7mm, which means the needle is thin and short for more comfortable injections. The syringe has a capacity of 0.3 mL, which is the amount of insulin it can hold. The barrel of the syringe is marked with clear, easy-to-read lines for accurate dosage measurement. The syringe is designed for single-use only and should be properly disposed of after each injection
In Parkinsons disease, for example, differences between normative and patient-specific brain connectivity from easier to define gray matter DBS targets (subthalamic nucleus, globus pallidus) may be smaller [59] than in many psychiatric disorders that may need more individualization given that targets are located at critical junctions of white matter networks (internal capsule, subcallosal cingulate-SCC) that are complex and variable [60, 61]
De Vincenzo R, Ferlini C, Distefano M, Gaggini C, Riva A, Bombardelli E, Morazzoni P, Valenti P, Belluti F, Ranelletti FO, Mancuso S, Scambia G (2000) In vitro evaluation of newly developed chalcone analogues in human cancer cells
